A Therapeutic Equivalence Study in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension

  • STATUS
    Recruiting
  • participants needed
    666
  • sponsor
    Sun Pharmaceutical Industries Limited
Updated on 29 November 2022
hypertension
glaucoma
ocular hypotensive
brinzolamide
hypotensive
primary open angle glaucoma
azopt
brinzolamide ophthalmic suspension

Summary

This is a randomized, Investigator-masked, multi-center, parallel group, therapeutic equivalence study with clinical endpoint.

Details
Condition Primary Open Angle Glaucoma, Ocular Hypertension
Treatment Brinzolamide ophthalmic suspension, Brinzolamide ophthalmic suspension, Azopt®
Clinical Study IdentifierNCT05022004
SponsorSun Pharmaceutical Industries Limited
Last Modified on29 November 2022

Similar trials to consider

Loading...

Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note